Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.
about
Annual deterioration of renal function in hypertensive patients with and without diabetes.Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?Discrepancies in Clinic and Ambulatory Blood Pressure in Korean Chronic Kidney Disease PatientsEffect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension.Hypertension in Chronic Kidney Disease.Masked hypertension: understanding its complexity.BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols.Masked Hypertension is Associated With Cognitive Decline in Geriatric Age-Geriatric MASked Hypertension and Cognition (G-MASH-cog) Study.An Update on Masked Hypertension.Albuminuria and masked uncontrolled hypertension in chronic kidney disease.Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis.Genetic risk factors influence nighttime blood pressure and related cardiovascular complications in patients with coronary heart disease.Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients.Masked hypertension and kidney function decline: the Jackson Heart Study.Masked uncontrolled hypertension in patients on maintenance hemodialysis.Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
P2860
Q33875371-202D31A8-CB14-4BD9-B850-47C6AF1A53A4Q37616714-D4D9B7D2-CC9B-4BFF-8928-33430120306CQ37740460-2328C3D8-E697-4A8A-ADED-F00AEA574BCDQ38384615-4DE194A7-2051-4533-82B2-1359869B9507Q38966241-C7CF3669-8607-4745-A754-1AF1E0441C85Q39165623-505130D3-A35B-4130-AE1F-F0801FBE7BB7Q40478724-D3814B77-D11A-4A84-A83F-4DDDBFAFB80AQ46120095-663C710F-9B95-4CCB-8EC8-AFB0C65FB08CQ47610931-A6C7ADB2-6345-4DD7-9250-30EA5D026B7AQ47876337-5EE8A6E5-BCD6-4CDC-AC53-4852EBF157E2Q48040773-97DD52C3-E1E0-46ED-B3D9-2E7BEC9F2CBFQ49193149-88146F5A-6BC5-40D3-985A-7948AD42FA79Q49596699-735428A3-EE15-4E85-80D7-16F60A30D453Q50050645-D2BEE0E7-F870-4FFB-9B3C-0955E23CA076Q53697281-40DEDBAB-5345-4C70-B53E-05DBD147F4E4Q54255917-9141F03F-B39F-47C7-B193-CC66D28911FDQ58765668-FB05BFCE-B6F6-4517-9522-22AAD7CFC816
P2860
Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Masked Hypertension and Elevat ...... tion with Target Organ Damage.
@ast
Masked Hypertension and Elevat ...... tion with Target Organ Damage.
@en
type
label
Masked Hypertension and Elevat ...... tion with Target Organ Damage.
@ast
Masked Hypertension and Elevat ...... tion with Target Organ Damage.
@en
prefLabel
Masked Hypertension and Elevat ...... tion with Target Organ Damage.
@ast
Masked Hypertension and Elevat ...... tion with Target Organ Damage.
@en
P2093
P2860
P356
P1476
Masked Hypertension and Elevat ...... tion with Target Organ Damage.
@en
P2093
Amanda H Anderson
Arnold B Alper
Carolyn S Brecklin
Chi-Yuan Hsu
Chronic Renal Insufficiency Cohort Study Investigators
Edgar R Miller
Elsayed Z Soliman
Gail K Makos
Jackson T Wright
P2860
P304
P356
10.2215/CJN.08530815
P577
2016-02-18T00:00:00Z